| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 4.168.668.723 $ | +439.468.435 $ | +9,1 % | 4.216.885.668 $ | +1.517.562.439 $ | +53,7 % | 2.505.289.939 $ | +577.348.080 $ | +30,3 % | |
| FMR LLC | 974.488.873 $ | +279.756.520 $ | +40,3 % | 694.732.353 $ | +361.946.364 $ | +108,8 % | 332.785.989 $ | +95.733.766 $ | +40,4 % |
| BAKER BROS. ADVISORS LP | 721.061.686 $ | +47.441.686 $ | +7,0 % | 673.620.000 $ | +297.149.119 $ | +78,9 % | 376.470.881 $ | +86.202.519 $ | +29,7 % |
| Avoro Capital Advisors LLC | 622.571.678 $ | +40.961.614 $ | +7,0 % | 581.610.064 $ | +222.200.064 $ | +61,8 % | 359.410.000 $ | +73.325.580 $ | +25,6 % |
| VANGUARD GROUP INC | 487.685.380 $ | +180.815.915 $ | +58,9 % | 306.869.465 $ | +61.619.299 $ | +25,1 % | |||
| BVF INC/IL | 458.320.716 $ | +30.154.851 $ | +7,0 % | 428.165.865 $ | +116.712.479 $ | +37,5 % | 311.453.386 $ | +71.315.122 $ | +29,7 % |
| BlackRock, Inc. | 421.520.382 $ | +32.151.731 $ | +8,3 % | 389.368.651 $ | +142.284.292 $ | +57,6 % | 247.084.359 $ | +66.054.279 $ | +36,5 % |
| Atlas Venture Life Science Advisors, LLC | 381.302.286 $ | +18.717.490 $ | +5,2 % | 362.584.796 $ | +85.445.047 $ | +30,8 % | 277.139.749 $ | +63.458.147 $ | +29,7 % |
| WELLINGTON MANAGEMENT GROUP LLP | 323.972.031 $ | -19.398.286 $ | -5,6 % | 343.370.317 $ | +49.294.207 $ | +16,8 % | 294.076.110 $ | +59.639.368 $ | +25,4 % |
| Siren, L.L.C. | 265.431.071 $ | +9.682.829 $ | +3,8 % | 255.748.242 $ | +61.714.952 $ | +31,8 % | |||
| 4.168.668.723 $ | +439.468.435 $ | +9,1 % | 4.216.885.668 $ | +1.517.562.439 $ | +53,7 % | 2.505.289.939 $ | +577.348.080 $ | +30,3 % | |